NEURODEGENERATIVE DISEASES, SYMPTOMS AND TREATMENT

Home  /   E-Books
neurodegenerative-diseases-symptoms-and-treatment

Open Access E-Books

919 North Market Street Suite 425 Wilmington, DE 19801

E-mail: info@openaccessebooks.com

ISBN: 978-93-87500-08-2


Editors:


1. Fuzheng Guo
2. Anand Venkatraman

Neurons cannot regenerate or replace themselves in the body so this condition leads to neurodegenerative diseases. They are mainly caused due to loss of structure or function of nervous systems. This condition may lead to degeneration or death of nerve cells. Ataxia and Dementia Problems may occur. Open Access eBooks is inviting researchers to submit their book chapter for the publication in volume 1 of an eBook NEURODEGENERATIVE DISEASES, SYMPTOMS AND TREATMENT.

All received book chapters undergo review process and are published on our website in PDF and HTML formats.

Benefits of publishing with us:

Universal Access: eBooks published in Open Access eBooks gain international visibility. No region barriers and content is accessed by everyone across the world from our website. We also deposit published eBooks in different databases.

Freely Available: Open Access eBooks follows the principles of Open Access and the content is available to the readers without any cost. Readers can read, share, and store the published ebooks/book chapters.

Copyright with Authors: As an eBook publisher, we serve researchers in publishing their valuable work after the stringent review process. However, copyright lies with authors. We follow the CC-BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/3.0/).

Different Formats: We provide eBooks in PDF and HTML formats. Both formats are user friendly and can act as per the user requirements. We put our efforts to provide other formats in future.

For more information, contact info@openaccessebooks.com

Published Chapters:

Parkinson's Disease (PD)


Author(s) : Sachchida Nand Rai

Parkinson's disease (PD) is a common and complex neurological disorder. The detailed description of PD was firstly made almost two centuries ago, but the conceptualisation of the disease is yet to be evolved. Basically, PD is a neurodegenerative disease in which there is an early prominent death of dopaminergic neurons in the substantia nigra pars compacta (SNpc).The pars compacta is a portion of the substantia nigra, located in the midbrain. It is formed by dopaminergic neurons and located medial to pars reticulata. Parkinson's disease is characterized by the death of dopaminergic neurons in this region [1]. In humans, the nerve cell bodies of the pars compacta are coloured black by the pigment neuromelanin. The degree of pigmentation increases with age. This pigmentation is visible as a distinctive black stripe in brain sections and is the origin of the name given to this volume of the brain. Thus, dopamine deficiency within the basal ganglia leads to a movement disorder characterised by classical parkinsonian motor symptoms. PD is also linked with numerous non-motor symptoms, some of which head the motor dysfunction by more than a decade. The stronghold of PD management is suggestive treatment with drugs that increase dopamine concentrations or directly stimulate dopamine receptors.

New eBooks